4-bromo-1-(methanesulfonylmethyl)-1H-pyrazole, 97.0%, 250mg

4-(2-fluorobenzoyl)-8-propyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

(4S,4'S)-4,4'-Diisopropyl-1,1'-bis(3-isopropylphenyl)-4,4',5,5'-tetrahydro-1H,1'H-2,2'-biimidazole, 98%, 250mg

(3-Methyl-1H-pyrazolo[3,4-b]pyridin-5-yl)boronic acid, 97%, 250mg

7-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-1,4-dihydro-2h-benzo[d][1,3]oxazin-2-one, 98%, 250mg

(E)-2-(2-BENZYLIDENEHYDRAZINYL)BENZOIC ACID, 95.0%, 250mg

trans-4-(4-Chlorophenyl)cyclohexanecarboxylic acid, 98%, 500g

(2,3,5,6-Tetrafluorophenyl)boronic acid, 96%, 1g

8-Bromoquinazolin-2-amine, 95.0%, 250mg

[2-(cyclopentylthio)ethyl]amine, 1g

2-(tert-Butoxycarbonyl)-6-methoxy-1,2,3,4-tetrahydroisoquinoline-1-carboxylic acid, 95.0%, 100mg

(S)-Ethyl 2-(3-amino-2-oxopiperidin-1-yl)acetate hydrochloride, 95.0%, 1g

Dialysis systems Spectra/Por® Float-A-Lyzer® G2 Filling volume 10 ml, 100–500 dalton(s), 12 Piece(s)